We are live on ! Find out more
NPTN

NEOPHOTONICS CORP

Delisted

NPTN was delisted on the 2nd of August, 2022.

147 hedge funds and large institutions have $551M invested in NEOPHOTONICS CORP in 2016 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 40 increasing their positions, 57 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more capital invested

Capital invested by funds: $316M → $551M (+$235M)

56% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 25

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

11% more funds holding

Funds holding: 133147 (+14)

30% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 57

34% less call options, than puts

Call options by funds: $3.48M | Put options by funds: $5.26M

Holders
147
Holders Change
+14
Holders Change %
+10.53%
% of All Funds
3.92%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
39
Increased
40
Reduced
57
Closed
25
Calls
$3.48M
Puts
$5.26M
Net Calls
-$1.78M
Net Calls Change
-$1.91M
Name Holding Trade Value Shares
Change
Change in
Stake
RFC
76
Regions Financial Corp
Alabama
$1M -$149K -10,577 -15%
ACM
77
Ativo Capital Management
Illinois
$920K -$177K -12,600 -18%
1CM
78
1492 Capital Management
Wisconsin
$898K -$711K -50,503 -48%
Wells Fargo
79
Wells Fargo
California
$874K -$306K -21,734 -29%
Victory Capital Management
80
Victory Capital Management
Texas
$872K -$140K -9,934 -16%
TA
81
Teachers Advisors
New York
$851K +$80.6K +5,730 +12%
Swiss National Bank
82
Swiss National Bank
Switzerland
$833K +$165K +11,700 +30%
BCM
83
Bridgeway Capital Management
Texas
$817K -$6.33K -450 -0.9%
OAM
84
Oxford Asset Management
United Kingdom
$804K +$418K +29,692 +152%
Axa
85
Axa
France
$796K -$808K -57,397 -54%
SCA
86
Secor Capital Advisors
New York
$719K +$619K +44,004 New
VKH
87
Virtu KCG Holdings
New York
$718K +$619K +43,951 New
Jacobs Levy Equity Management
88
Jacobs Levy Equity Management
New Jersey
$681K -$734K -52,160 -56%
Verition Fund Management
89
Verition Fund Management
Connecticut
$654K +$563K +40,000 New
RhumbLine Advisers
90
RhumbLine Advisers
Massachusetts
$590K -$51.2K -3,635 -9%
US Bancorp
91
US Bancorp
Minnesota
$562K -$76.6K -5,443 -14%
MERSOM
92
Municipal Employees' Retirement System of Michigan
Michigan
$556K
NIT
93
NumerixS Investment Technologies
British Columbia, Canada
$541K +$466K +33,100 New
GGHC
94
Gilder Gagnon Howe & Co
New York
$523K +$450K +31,991 New
ID
95
Integral Derivatives
New York
$520K +$448K +31,850 New
UBS AM
96
UBS AM
Illinois
$505K +$435K +30,900 New
State Board of Administration of Florida Retirement System
97
State Board of Administration of Florida Retirement System
Florida
$500K
AllianceBernstein
98
AllianceBernstein
Tennessee
$438K +$19.7K +1,400 +6%
AG
99
Algert Global
California
$420K +$114K +8,077 +46%
FRM
100
Fox Run Management
Connecticut
$399K +$343K +24,400 New

NPTN Hedge Fund Activity: Q3 2016 in Review

147 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in NEOPHOTONICS CORP (NPTN) for Q3 2016, worth a combined $551M — up 75% from $316M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new NPTN positions and 25 closed out — a net gain of 14 holders — while 40 added to existing stakes and 57 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $8.79M. The largest seller was Northpointe Capital, cutting an estimated $6.21M.

  • 147 institutional investors held NEOPHOTONICS CORP (NPTN) as of Q3 2016, up from 133 in Q2 2016.
  • Funds reported $551M of NEOPHOTONICS CORP stock for Q3 2016, up 75% quarter-over-quarter.
  • 39 funds opened new NEOPHOTONICS CORP positions in Q3 2016 and 25 closed out, a net change of +14 holders.
  • The largest NEOPHOTONICS CORP buyer in Q3 2016 was Goldman Sachs, an estimated $8.79M added.
  • The largest NEOPHOTONICS CORP seller in Q3 2016 was Northpointe Capital, an estimated $6.21M sold.

Based on aggregated 13F filings for Q3 2016.